IMI PLC

Completion of Adaptas Solutions acquisition

RNS Number : 1105W
IMI PLC
20 December 2021
 

 

20 December 2021   

 

 

Completion of Adaptas Solutions ("Adaptas") acquisition

IMI plc, the specialist engineering group, confirms that further to the announcement made on 15 November 2021, the acquisition of Adaptas has been completed.

Roy Twite, Chief Executive of IMI said:

"I would like to welcome Adaptas and all its employees to IMI. With Adaptas, we have created a significant opportunity to enhance IMI's current position in the Life Science Instrumentation markets. Our combined expertise will help solve more industry problems and deliver our purpose: [Breakthrough Engineering for a better world]."

 

 




Enquiries to:

John Dean

IMI

Tel: +44 (0)121 717 3712

Stephen Malthouse

Headland PR

Tel: +44 (0)7734 956 201



Notes to editors

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids.  Its innovative technologies, built around valves and actuators, enable vital processes to operate safely, sustainably, cleanly, efficiently and cost effectively.  IMI employs around 10,000 people, has manufacturing facilities in 18 countries and operates a global service network.  The Company is listed on the London Stock Exchange.  Further information is available at www.imiplc.com .

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQTRBBTMTIBTFB